# Timing Effect on Transient Evoked Otoacoustic Emission Referral Rates for Newborn Hearing Screening within and after 48 Hours of Birth

**Authors:** Chuan Cheepcharoenrat, Amaraporn Rerkasem

PMC · DOI: 10.1055/s-0045-1802580 · International Archives of Otorhinolaryngology · 2025-07-29

## TL;DR

This study finds that newborn hearing screening using TEOAEs has higher referral rates when done within 48 hours of birth, with a recommendation to add AABR for early discharge cases.

## Contribution

The study identifies optimal timing for TEOAE testing and suggests adding AABR to improve screening accuracy for early-discharged infants.

## Key findings

- Referral rates were 53% within 48 hours and 46% after 48 hours (p=0.001).
- Highest referral rates were observed in infants tested between 25 to 36 hours.
- No significant difference in referral rates for high-risk infants tested before or after 48 hours.

## Abstract

Newborn hearing screenings must be completed within 48 hours of birth.

To determine the optimal timing for the first transient evoked otoacoustic emissions (TEOAEs) test by comparing the referral rates of infants tested between different time intervals.

The present study was a retrospective cohort analysis of 2,713 newborns who underwent TEOAE tests between February 2021 and June 2022. The infants were categorized into groups according to the age at which they were tested: 12 to 24 hours, 25 to 36 hours, 37 to 48 hours, and > 48 hours. We compared referral rates across these groups.

The overall referral rate for infants tested within 48 hours from birth was 53%, significantly higher than the rate for those tested after 48 hours (46%,
p
 = 0.001). Notably, the highest referral rates were observed in neonates aged 25 to 36 hours. However, no significant difference in referral rates was found for high-risk infants tested either before or after 48 hours.

Transient evoked otoacoustic emissions can be used to screen newborns' hearing within 48 hours, but the high referral rate suggests that Thailand should add automated auditory brainstem response (AABR) to its guidelines for hearing evaluation if newborns leave the hospital before 48 hours.

## Full-text entities

- **Diseases:** hypoxia (MESH:D000860), middle ear effusion (MESH:D010034), hereditary hearing loss (MESH:D009386), phenylketonuria (MESH:D010661), atresia or stenosis of the external ear canal (MESH:D010032), delayed speech development (MESH:D007805), hyperbilirubinemia (MESH:D006932), hearing impairment (MESH:D034381), Congenital and progressive hearing loss (MESH:D003638), congenital hypothyroidism (MESH:D003409), ototoxic (MESH:D006311), anxiety (MESH:D001007), AABR (MESH:C537159), TEOAE (MESH:C563551)
- **Chemicals:** oxygen (MESH:D010100), furosemide (MESH:D005665), EC (-), tobramycin (MESH:D014031), gentamicin (MESH:D005839), CR (MESH:D002857)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12307080/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12307080/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12307080/full.md

---
Source: https://tomesphere.com/paper/PMC12307080